Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Amarantus Bioscience Holdi AMBS
Posted On: 11/18/2014 10:22:10 AM
Post# of 30066
Avatar
Posted By: Warp
Re: Chrisdc73 #11197
Quote:
Eltoprazine possibility of moving right in to Phase 3 is massive news and something I think that will happen.

Sorry, but I don't recall hearing that in the presentation. GC mentioned several times that Eltoprazine was on track to begin Phase 2b clinical trial. I'll review archive and report back if I'm wrong on this. Anyone else remember hearing this?

Recent Operational Highlights (Slide 3)
Eltoprazine
Submitted a request for written feedback to the FDA regarding the proposed trial design for a Phase 2b clinical study in PD LID, expected to start in early 2015. The Company expects to receive written feedback in the coming weeks.

AMBS Near-Term Milestones (Slide 26)
Eltoprazine
• IND Submission/approval
• Initiation of Eltoprazine Phase 2b clinical study in PD LID anticipated for early Q1/2015
• Initiation of the Phase 2b adult ADHD clinical trial with Eltoprazine anticipated for later in 2015













(0)
(0)









  • New Post - Investors HangoutNew Post

  • Public Reply - Investors HangoutPublic Reply

  • Private Reply - Investors HangoutPrivate Reply

  • Board - Investors HangoutBoard

  • More - Investors HangoutMore

  • Keep Post - Investors HangoutKeep Post
  • Report Post - Investors HangoutReport Post
  • Home - Investors HangoutHome
  • Mailbox - Investors HangoutMailbox
  • Boards - Investors HangoutBoards
  • Favorites - Investors HangoutFavorites
  • Whats Hot! - Investors HangoutWhats Hot!
  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site